Otradi
Oregon Translational Research and Drug Development Institute (OTRADI)
A Unique Opportunity for Oregon Researchers
OTRADI brings the lab to the market via partnerships with Oregon universities, private bioscience companies, the life science industry, and public and private funders. Partnering with OTRADI offers many advantages:
Grant Partnering
- OTRADI is actively involved in grant writing & support to attract additional and new federal and private funding to Oregon university researchers and small businesses
- OTRADI Innovation and Commercialization Funds (OICF) are available for bioscience researchers at Oregon small businesses or Oregon universities to support and promote projects with potential for future commercialization.
- OTRADI partners with university researchers & small biotech companies to help produce preliminary data in new areas & helps develop strategies & helps write grants
When grants are funded OTRADI continues working with investigator as a subcontractor on grant
Investigators have access to bioscience accelerator opportunities for licensing and commercialization of novel chemicals and drug targets
Training
- Researchers, faculty, postdocs & students
- Internships & fellowships
Expertise
- Experience and knowledge in assay development for cell biology, pharmacology, infectious diseases, cancer, inflammatory diseases, etc.
Instrumentation & Resources
- State-of-the-art drug discovery robotic equipment for high-throughput & high-content screening
- Novel and commercially available chemical compound libraries comprised of more than 60,000 compounds for screening
How to Partner with OTRADI
Oregon university researchers and small businesses are encouraged to join OTRADI as Affiliated Researchers. As such, Affiliated Researchers are qualified to collaborate with OTRADI and apply for OTRADI Innovation and Commercialization Funds (OICF). Partnering with OTRADI allows researchers access to unique expertise and drug-discovery equipment as well as help with assay development, grant writing and achieving the new steps to commercialization of new drug discoveries in Oregon. To learn more contact OTRADI's Executive Director M. Patricia Beckmann, Ph.D. at pbeckmann@otradi.org or 503-227-1814.